Disturbances in the gut microbiota have also been found to be a risk factor for the development of MetS, and alterations in the gut microbiome have been connected to insulin sensitivity, glucose metabolism, and obesity (Nicholson et al., 2012; Utzschneider et al., 2016). Here, INS is linked to metabolic syndrome.